20020 ⎘
Medicinal preparations characterised by special physical form; Galenical forms characterised by the site of application Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Methods of treating inflammation and/or pain
#4202PREVENTION OF BOAR TAINT AND AGGRESSION
#4203TETRAHYDROPYRIDOETHERS FOR TREATMENT OF AMD
#4204GLUTAMINASE INHIBITOR DISCOVERY AND NANOPARTICLE-ENHANCED DELIVERY FOR CANCER THERAPY
#4205FULVESTRANT PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF
#4206POLYNUCLEOTIDES ENCODING METHYLMALONYL-COA MUTASE FOR THE TREATMENT OF METHYLMALONIC ACIDEMIA
#4207Methods, agents, and devices for local neuromodulation of autonomic nerves
#4208Antisense oligomers and methods of using the same for treating diseases associated with the acid alpha-glucosidase gene
#4209COMPOSITIONS AND METHODS FOR EDITING THE ANGIOPOIETIN-LIKE 4 (ANGPTL4) GENE
#4210METHODS FOR TREATING PROGRESSIVE MULTIPLE SCLEROSIS
#4211Anti-lag-3 antibodies and compositions
#4212METHODS OF TREATING AUTOIMMUNE DISEASES USING INTERLEUKIN-17 (IL-17) ANTAGONISTS
#4213ANTI-ANGPT2 ANTIBODIES
#4214COMPOSITION COMPRISING HYALURONIC ACID AND MEPIVACAINE
#4215Optimized promoter sequences, intron-free expression constructs and methods of use
#4216LIPID NANOPARTICLE COMPOSITIONS AND METHODS FOR MRNA DELIVERY
#4217AAV-ABCD1 CONSTRUCTS AND USE FOR TREATMENT OR PREVENTION OF ADRENOLEUKODYSTROPHY (ALD) AND/OR ADRENOMYELONEUROPATHY (AMN)
#4218COMPOSITIONS AND ARTICLES COMPRISING (NANO)DIAMOND PARTICLES
#4219RECEPTOR TARGETING CONSTRUCTS AND USES THEREOF
#4220RNA FORMULATIONS SUITABLE FOR THERAPY
#4221WIDE-SPECTRUM ANTIBACTERIAL PHARMACEUTICAL FORMULATIONS COMPRISING LYSOZYME AND METHODS OF USING THE SAME
#4222Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited thereby
#4223Compositions and methods for treating heart failure
#4224TREATMENT OF NEUROPATHIC PAIN ASSOCIATED WITH CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY
#4225Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#4226TREATMENT OF BONE MARROW EDEMA (OEDEMA) WITH POLYSULFATED POLYSACCHARIDES
#4227NOVEL PHARMACEUTICAL FORMULATION
#4228Methods and compositions for treatment of epileptic disorders
#4229Pharmaceutical compositions comprising levodopa, a dopamine decarboxylase inhibitor and a COMT inhibitor and method of administration thereof
#4230DOSAGES AND USES OF ORNITHINE PHENYLACETATE FOR TREATING HYPERAMMONEMIA
#4231Norepinephrine compositions and methods therefor
#4232PHARMACEUTICAL COMPOSITION FOR REDUCING LOCAL FAT AND USES THEREOF
#4233CHIMERIC COMPLEX AND THERAPEUTIC USES THEREOF
#4234ANTI-SECRETOGRANIN III (SCG3) ANTIBODIES AND USES THEREOF
#4235T-cell modulatory multimeric polypeptides and methods of use thereof
#4236COMPLEXES OF IL-15 AND IL-15RALPHA IN COMBINATION WITH ANTI-PD-1 ANTIBODY MOLECULES AND USES THEREOF
#4237Therapeutic oligonucleotides
#4238Lanthanide complex formulations
#4239Hydrogel prodrug for treatment
#4240Hydrogel prodrug for treatment
#4241BIODEGRADABLE DRUG DELIVERY FOR HYDROPHOBIC COMPOSITIONS
#4242VACCINATION AGAINST FUNGAL EPITOPES TO PREVENT INFLAMMATORY BOWEL DISEASES
#4243METHODS AND COMPOSITIONS OF NEUREGULINS FOR PREVENTING, TREATING OR DELAYING PRESERVED EJECTION FRACTION CARDIAC FAILURE
#4244Glycopeptide compositions
#4245COMPOSITIONS AND METHODS FOR THE TREATMENT OF RETINAL DEGENERATION
#4246Cell Composition Comprising Radiolabled Mesenchymal Stem Cells, Use Thereof and Method for Preparing Radiolabeled Mesenchymal Stem Cells
#4247LIPOSOME DELIVERY OF PSYCHEDELICS
#4248Subcutaneous delivery of polymer conjugates of therapeutic agents
#4249Equine Esomeprazole Formulations and Methods of Use
#4250CONTROLLED RELEASE INJECTABLE ONDANSETRON FORMULATIONS
#4251Multifunctional Nanoparticles For Prevention And Treatment Of Atherosclerosis
#4252Lyophilized formulations for factor XA antidote
#4253In vivo bulking agent, injection comprising same, and preparation method therefor
#4254POLYETHYLENIMINE NANOPARTICLES AND METHODS OF USING SAME
#4255SUBCUTANEOUSLY INJECTABLE INSULIN AND GLUCAGON FORMULATIONS AND METHODS OF ADMINISTRATION
#4256NANOFIBER- AND NANOWHISKER-BASED TRANSFECTION PLATFORMS
#4257p63 inactivation for the treatment of heart failure
#4258Xenogen-Free Mesenchymal Stem Cell Compositions and Methods of Use
#4259Quantitative Spatial Profiling for LAG-3 Antagonist Therapy
#4260METHODS AND COMPOSITIONS FOR THE EXPRESSION OF CONSTITUTIVELY ACTIVE RAP1A FROM A VMD2 PROMOTER
#4261Vaccine delivery method
#4262VACCINE FOR THE PREVENTION OF BREAST CANCER RELAPSE
#4263CD200 inhibitors and methods of use thereof
#4264HIGH CONCENTRATION ALPHA-GLUCOSIDASE COMPOSITIONS FOR THE TREATMENT OF POMPE DISEASE
#4265USE OF FKBP-L POLYPEPTIDES AND NUCLEIC ACIDS FOR THE TREATMENT OF OBESITY
#4266PREPARATION OF PHAGE COCKTAIL AS THERAPEUTIC AGENT FOR COW MASTITIS AND USE THEREOF
#4267Composition comprising probiotics and polypeptide having binding affinity for IgE and use thereof
#4268Generating CIK NKT cells from cord blood
#4269PROPHYLACTIC AND THERAPEUTIC USE OF MITOCHONDRIA AND COMBINED MITOCHONDRIAL AGENTS
#4270Highly active compounds against COVID-19
#4271Highly active compounds against COVID-19
#4272Method for treating HIV with Cabotegravir and Rilpivirine
#4273COMBINATIONS OF GABA-A RECEPTOR POSITIVE ALLOSTERIC MODULATORS AND NMDA ANTAGONISTS, NMDA NEGATIVE ALLOSTERIC MODULATORS OR NMDA PARTIAL AGONISTS
#4274MEMBRANE LIPID COATED NANOPARTICLES AND METHOD OF USE
#4275LIPOSOMAL CANNABINOIDS AND USES THEREOF
#4276Methods of treatment with an ocular implant containing a tyrosine kinase inhibitor
#4277COMPOSITIONS AND METHODS FOR TREATING LEBER'S HEREDITARY OPTIC NEUROPATHY
#4278METHODS FOR THE TREATMENT OF THYROID EYE DISEASE
#4279CONSTRUCTION OF CHIMERIC ANTIGEN RECEPTOR TARGETING CD20 ANTIGEN AND ACTIVITY IDENTIFICATION OF ENGINEERED T CELLS THEREOF
#4280T-cell modulatory multimeric polypeptides and methods of use thereof
#4281Vaccine candidates for human respiratory syncytial virus (RSV) having attenuated phenotypes
#4282HUMAN GENE THERAPY METHODS FOR HEMOPHILIA A
#4283NANOPARTICLES FOR SELECTIVE TISSUE OR CELLULAR UPTAKE
#4284TREATMENT OF POST-TRAUMATIC STRESS DISORDER USING BOTULINUM TOXIN A
#4285SKIN THERAPEUTICS
#4286A METHOD FOR TREATING TUMOR BY USING RECOMBINANT INTERFERON WITH CHANGED SPATIAL CONFIGURATION
#4287METHODS FOR TREATING NEOINTIMAL HYPERLASIA USING F11R/JAM-A INHIBITORS
#4288Methods of treating Kawasaki disease
#4289AMMONIA OXIDIZING MICROORGANISMS FOR USE AND DELIVERY TO THE VISUAL AND AUDITORY SYSTEMS
#4290PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING RETINAL DEGENERATIVE DISEASE, COMPRISING HUMAN NEURAL CREST-DERIVED NASAL INFERIOR TURBINATE STEM CELLS AS ACTIVE INGREDIENT
#4291CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS
#4292Combination drugs of hypoxanthine and human immunoglobulin
#4293TAK-925 FOR USE IN TREATING NARCOLEPSY
#4294METHOD OF INITIATING AND ESCALATING SOTALOL HYDROCHLORIDE DOSING
#4295Composition for Preventing or Treating Salivary Gland Diseases Using Cell-Derived Vesicle
#4296THERMOSENSITIVE MODIFIED CHITIN HYDROGEL LOCAL ANESTHETIC-LOADED SUSTAINED-RELEASE ANALGESIA SYSTEM, PREPARATION METHOD AND USE
#4297ANTI-PD-L1 ANTIBODY TREATMENT OF BLADDER CANCER
#4298DOSING REGIMEN AND COMBINATION THERAPIES FOR MULTISPECIFIC ANTIBODIES TARGETING B-CELL MATURATION ANTIGEN
#4299NaPi2B-TARGETED POLYMER ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF
#4300TREATMENT METHODS FOR EYE DISORDERS
#4301NOVEL HPV16 NON HLA-RESTRICTED T-CELL VACCINES, COMPOSITIONS AND METHODS OF USE THEREOF
#4302ANTIVIRAL PRODRUGS AND PHARMACEUTICAL COMPOSITIONS THEREOF
#4303Compositions and methods for inhibiting Mand PLprotease activity and for preventing and treating SARS-CoV-2 infection
#4304COMPOSITIONS AND METHODS FOR TREATING SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY (SSADHD)
#4305Immunoconjugates targeting CD46 and methods of use thereof
#4306Animal protein-free pharmaceutical compositions
#4307SEASONAL INFLUENZA VACCINE CAPABLE OF INDUCING VIRUS-SPECIFIC ANTIBODY INTO NASAL CAVITY
#4308NEUROTOXIN COMPOSITIONS FOR USE IN TREATING GASTROPARESIS
#4309METHODS AND COMPOSITIONS FOR TREATMENT OF CARTILAGE DAMAGE AND ARTHRITIS
#4310TREATMENT METHODS USING ADENOVIRUS
#4311Bacteriophages for treatment of tuberculosis
#4312TREATMENT OF CARDIOVASCULAR DISEASES
#4313Methods of treating retinal vasculopathies
#4314PHARMACEUTICAL COMPOSITION WITH LOW-CONTENT FLURBIPROFEN AXETIL (FPA), AND USE THEREOF
#4315BIODEGRADABLE POLYMERIC PARTICLES ENCAPSULATING AN ACTIVE AGENT, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
#4316Methods and compositions for retinal drug delivery
#4317N-acetylcysteine compositions and methods
#4318THANOTRANSMISSION POLYPEPTIDES AND THEIR USE IN TREATING CANCER
#4319Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof
#4320MAGE-A4 T CELL RECEPTORS AND METHODS OF USE THEREOF
#4321Peptide analogs
#4322THERAPEUTIC PEPTIDES
#4323Hepatitis B Virus (HBV) Vaccines and Uses Thereof
#4324Modified peptide nucleic acid compositions
#4325TRITERPENOID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR USE FOR TREATING A NUCLEAR RECEPTOR SUBFAMILY 4 GROUP A MEMBER 1-MEDIATED DISEASE
#4326Methods of treating non-hodgkin lymphoma using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione
#4327Dantrolene prodrugs and methods of their use
#4328Ocular applications of silk-based products
#4329DISSOLVABLE FILMS AND METHODS OF THEIR USE
#4330Anhydrous sodium thiosulfate and formulations thereof
#4331FORMULATIONS OF BENDAMUSTINE
#4332ANTI-TNF ANTIBODY COMPOSITIONS, AND METHODS FOR THE TREATMENT OF PSORIATIC ARTHRITIS
#4333DOSING AND ADMINISTRATION OF RECOMBINANT L-ASPARAGINASE
#4334Collagenase Clostridium for Treating Esophageal Ailments
#4335Compositions and methods for the treatment of fungal infections
#4336METHODS FOR TREATING METASTATIC STAGE PROSTATE CANCER
#4337Oligodendrocyte-derived Extracellular Vesicles for Therapy of Multiple Sclerosis
#4338LNP-FORMULATED MRNA THERAPEUTICS AND USE THEREOF FOR TREATING HUMAN SUBJECTS
#4339ANTIVIRAL PRODRUGS AND FORMULATIONS THEREOF
#4340COMBINATION THERAPY FOR CANCER
#4341SUSTAINED RELEASE OLANZAPINE FORMULATIONS
#4342METHODS AND COMPOSITIONS FOR TREATING NEUROBLASTOMA IN A JUVENILE MAMMALIAN BODY
#4343Methods and compositions for treatment of epileptic disorders
#4344Method for treating inflammatory disorders
#4345COMPOSITIONS FOR THE TREATMENT OF SOLID TUMORS
#4346COMPOSITION USED FOR COMBATING METABOLIC DISEASES AND USES OF COMPOSITION
#4347Ribose cationic lipids
#4348HUMANIZED ANTIBODY FOR SARS-CoV-2 SPIKE PROTEIN INFUSION
#4349Hyperbranched polyglycerol-coated particles and methods of making and using thereof
#4350COMPOSITIONS AND METHODS FOR IMPROVING TUMOR PENETRATION OF TUMOR SPECIFIC ANTIBODIES
#4351GDF15 ANALOGS AND METHODS FOR USE IN DECREASING BODY WEIGHT AND/OR REDUCING FOOD INTAKE
#4352Radiopharmaceuticals, radioimaging agents, and uses thereof
#4353HYALURONIC ACID-BASED GELS INCLUDING LIDOCAINE
#4354Chimeric protein and related genic transfer technology
#4355COMPOSITIONS AND METHODS FOR TREATING NERVOUS SYSTEM INJURIES
#4356HEPARIN-PEPTIDE BIOCONJUGATES AND USES THEREOF
#4357PHOTODYNAMIC THERAPY METHOD MEDIATED BY CHLORIN E6 PHOTOSENSITIZER COMPOSITE FOR TREATING AND PREVENTING OBESITY
#4358FORMULATION FOR ADMINISTRATION OF RNA
#4359Compositions and methods for generating an immune response to treat or prevent malaria
#4360DOSING OF RECOMBINANT L-ASPARAGINASE
#4361Methods of treating spinal cord injury
#4362HEMOGLOBIN-BASED NANOPARTICLES FOR OXYGEN DELIVERY
#4363Method of Treating a Child with Central Precocious Puberty using an Extended Release Composition
#4364IMMUNOTHERAPY FOR ANGIOGENIC DISEASE
#4365CORONAVIRUS THERAPEUTIC AGENT INCLUDING Elaeocarpus sylvestris EXTRACT AS ACTIVE INGREDIENT
#4366METHOD OF TREATING ALZHEIMER'S DISEASE
#4367COMPOSITIONS FOR INTRATUMORAL ADMINISTRATION AND RELATED METHODS
#4368TARGETED CANCER THERAPY
#4369Amorphous solid dispersions
#4370SYNERGISTIC EFFECT OF EYP001 AND IFN FOR THE TREATMENT OF HBV INFECTION
#4371Short-Acting Dihydropyridines (Clevidipine) For Use in Reducing Stroke Damage
#4372Emulsions for local anesthetics
#4373METHOD OF TREATING LIVER FIBROSIS
#4374COMPOUNDS AND METHODS FOR THE TREATMENT OF PARASITIC INFECTIONS
#4375TREATMENT OF BREAST CANCER
#4376Methods of treatment using mutant FGF-21 peptide conjugates
#4377NEUROTOXINS FOR USE IN INHIBITING CGRP
#4378OCULAR DELIVERY OF THERAPEUTIC AGENTS
#4379COMPOSITIONS AND ARTICLES COMPRISING (NANO)DIAMOND PARTICLES
#4380DNA NANOSTRUCTURE-BASED VACCINES
#4381LIPID NANOPARTICLE OR LIPOSOME DELIVERY OF HEPATITIS B VIRUS (HBV) VACCINES
#4382Methods of treating atopic dermatitis
#4383CORE/SHELL STRUCTURE PLATFORM FOR IMMUNOTHERAPY
#4384HIGH FREQUENCY APPLICATION OF BOTULINUM TOXIN THERAPY
#4385HIGH FREQUENCY APPLICATION OF BOTULINUM TOXIN THERAPY
#4386PEPTIDE AMIDE COMPOSITION AND PREPARATION METHOD THEREFOR
#4387NITRITE FORMULATIONS AND USES THEREOF FOR THE TREATMENT OF LUNG INJURY
#4388USE OF HEPARIN TO PROMOTE TYPE 1 INTERFERON SIGNALING
#4389Method for preparing a liposomal composition comprising latanoprost, and the pharmacologically active liposomal composition for ophthalmotherapy prepared by this method
#4390INJECTABLE FORMULATION
#4391APPLICATION OF ALKALOID COMPOUND HIP IN TREATMENT OF CARDIAC TRAUMA
#4392Use of Carbamate Compound For Preventing, Alleviating Or Treating Myotonia
#4393CITRULLINE FOR TREATMENT OF SICKLE CELL CRISIS
#4394LYOPHILIZED POWDER OF LATAMOXEF SODIUM FOR INJECTION AND LYOPHILIZATION METHOD THEREOF
#4395Inhibition of Vascular Matrix Metalloproteinase-9 to Treat Ischemic Injury
#4396CONJUGATES AND CONJUGATES FOR USE IN PREVENTING OR TREATING OF BRAIN DAMAGE AND NEURODEGENERATIVE DISEASES
#4397METHOD FOR PREVENTING PRECIPITATION OF INJECTABLE SOLUTION CONTAINING p-BORONOPHENYLALANINE
#4398TREATMENT OF NEUROPATHIC PAIN ASSOCIATED WITH CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY
#4399SUSTAINED RELEASE FORMULATION COMPRISING OCTREOTIDE AND TWO OR MORE POLYLACTIDE-CO-GLYCOLIDE POLYMERS
#4400METHOD OF ENHANCING A BRAIN OR COGNITIVE FUNCTION
#4401Highly concentrated formulations of soluble Fc receptors
#4402TREATMENT OF CANCER BY MANIPULATION OF COMMENSAL MICROFLORA
#4403SODIUM THIOSULFATE GEL FOR PREVENTING OR REDUCING HEARING LOSS
#4404METHODS FOR TREATING MUSCULAR DYSTROPHY
#4405PHARMACEUTICAL FORMULATIONS OF TENOFOVIR ALAFENAMIDE
#4406Stable liquid formulations of cyclophosphamide and processes to prepare the same
#4407Pemetrexed formulations
#4408ORGANIC COMPOUNDS
#4409USE OF AMISULPRIDE AS AN ANTI-EMETIC
#4410PAMOATE SALT OF MONOAMINE ANTI-PARKINSON'S AGENTS, METHOD OF PREPARATION AND USE THEREOF
#4411INJECTABLE PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
#4412Single-injection methods and formulations to induce and control multiple ovarian follicles in bovine, caprine, ovine, camelid and other female animals
#4413Vancomycin Liposome Compositions and Methods
#4414MESENCHYMAL STEM CELLS WITH ENHANCED THERAPEUTIC PROPERTIES
#4415TGF-beta TRAP
#4416T-cell modulatory multimeric polypeptides and methods of use thereof
#4417ANTI-VIRAL COMPOSITIONS AND METHODS OF MAKING AND USING
#4418SYNTHETIC ANTIMICROBIAL PEPTIDES
#4419POLYMORPHIC FORMS OF (R)-4-(1-((3-(DIFLUOROMETHYL)-1-METHYL-1H-PYRAZOL-4-YL)SULFONYL)-1-FLUOROETHYL)-N-(ISOXAZOL-3-YL)PIPERIDINE-1-CARBOXAMIDE
#4420COMPOUNDS AND METHODS FOR DELIVERY OF PROSTACYCLIN ANALOGS
#4421COMPOSITIONS FOR TREATMENT OF WET AGE-RELATED MACULAR DEGENERATION
#4422EXONS 45-55 SKIPPING USING MUTATION-TAILORED COCKTAILS OF ANTISENSE MORPHOLINOS IN THE DMD GENE
#4423ASH1L inhibitors and methods of treatment therewith
#4424METHODS AND COMPOSITIONS FOR TREATING MUSCLE DISEASE AND DISORDERS
#4425GENERATION OF NEURONS BY REPROGRAMMING OF OLIGODENDROCYTES AND OLIGODENDROCYTE PRECURSOR CELLS
#4426Hydroxypropyl beta-cyclodextrin compositions and methods
#4427Hydroxypropyl beta-cyclodextrin compositions and methods
#4428ADENOSINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
#4429COMPOSITIONS AND METHODS FOR TREATING AN AGGREGATION DISEASE OR DISORDER
#4430COMBINATION OF IMMUNOTHERAPEUTICS AND BISFLUOROALKYL-1,4-BENZODIAZEPINONE COMPOUNDS FOR TREATING CANCER
#4431Use of EZH2 inhibitors for treating cancer
#4432Small molecule trail gene induction by normal and tumor cells as an anticancer therapy
#4433FORMULATIONS AND TREATMENT METHODS
#4434METHODS AND COMPOSITIONS FOR THE ANTIVIRAL USE OF SYNTHETIC LYSINE ANALOGS AND MIMETICS
#4435METHODS OF TREATING BACTERIAL INFECTIONS
#4436Methods and compositions for treating edema refractory to oral diuretics
#4437Intraarterial (IA) Application of Low Dose of Ethyl Alcohol Enables Blood-Brain Barrier (BBB) Impermeable Therapeutics Brain Entry
#4438TREATMENT APPROACH BY TARGETED DELIVERY OF BIOACTIVE MOLECULES
#4439Microbial compositions and methods of use for improving milk production
#4440High concentration antibody-containing liquid formulation
#4441FORMULATION COMPRISING ANTI-PD-1/HER2 BISPECIFIC ANTIBODY, METHOD FOR PREPARING SAME AND USE THEREOF
#4442Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof
#4443COMPOSITIONS AND METHODS FOR THE TREATMENT OF PATHOLOGICAL PAIN AND ITCH
#4444BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF
#4445INTERCELLULAR ADHESION MOLECULE 1 (ICAM1) ANTIBODY DRUG CONJUGATE AND USES THEREOF
#4446Dosage regimes for the administration of an anti-CD19 ADC
#4447Hydrophobic Peptide Salts for Extended Release Compositions
#4448COMPOSITIONS AND METHODS INVOLVING POLYMER, SOLVENT AND HIGH VISCOSITY LIQUID CARRIER MATERIAL
#4449METHODS OF TREATMENT USING A LEPTIN RECEPTOR AGONIST ANTIBODY
#4450COMPOSITIONS AND METHODS FOR DELIVERY OF RNA INTERFERENCE AGENTS TO IMMUNE CELLS
#4451IMMUNE TOLERANT ELASTIN-LIKE RECOMBINANT PEPTIDES AND METHODS OF USE
#4452METHOD FOR REDUCING FLU-LIKE SYMPTOMS ASSOCIATED WITH INTRAMUSCULAR ADMINISTRATION OF INTERFERON USING A FAST TITRATION ESCALATING DOSING REGIMEN
#4453COMPLEMENT INHIBITOR DOSING REGIMENS
#4454METHODS FOR PERFORMING A CORONARY ARTERY BYPASS GRAFT PROCEDURE
#4455Use For JNK Inhibitor Molecules For Treatment Of Various Diseases
#4456STROMAL CELLS DERIVED FROM NEONATAL FELINES AND USES THEREOF
#4457THERAPEUTIC APOPTOTIC CELLS FOR TREATMENT OF OSTEOARTHRITIS
#4458Hydroxypropyl beta-cyclodextrin compositions and methods
#4459Hydroxypropyl beta-cyclodextrin compositions and methods
#4460Hydroxypropyl beta-cyclodextrin compositions and methods
#4461Hydroxypropyl beta-cyclodextrin compositions and methods
#4462Hydroxypropyl beta-cyclodextrin compositions and methods
#4463Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treating viral infections
#4464INJECTION CONTAINING p-BORONOPHENYLALANINE
#4465Stable ready-to-use parenteral compositions of fosaprepitant
#4466LOW-SORBING GLYBURIDE FORMULATION AND METHODS
#4467Subcutaneously administered anti-IL-6 receptor antibody
#4468TRACE AMINE ASSOCIATED RECEPTOR 1 AGONISTS AND PARTIAL AGONISTS FOR PAIN TREATMENT
#4469TELODENDRIMERS WITH RIBOFLAVIN MOIETIES AND NANOCARRIERS AND METHODS OF MAKING AND USING SAME
#4470ENHANCING THE ANTIVIRAL EFFICACY OF RNA VIRUS INHIBITION BY COMBINATION WITH MODULATORS OF PYRIMIDINE METABOLISM
#4471Combination Therapy Including an MDM2 Inhibitor and One or More Additional Pharmaceutically Active Agents for the Treatment of Cancers
#4472PHARMACEUTICAL FORMULATIONS COMPRISING DICLOFENAC
#4473Membrane lipid coated nanoparticles and method of use
#4474METHOD AND COMPOSITION FOR TARGETED DELIVERY OF THERAPEUTIC AGENTS
#4475COMPOSITIONS AND METHODS FOR IN UTERO GENE EDITING FOR MONOGENIC LUNG DISEASE
#4476Use of Approved Anti-CD38 Antibody Drug Product to Treat Light Chain Amyloidosis
#4477COMPOSITIONS AND METHODS FOR TREATMENT OF THYROID EYE DISEASE
#4478Combination of TIM-4 antagonist and PD-1 antagonist and methods of use
#4479MULTIVALENT DNA ANTIBODY CONSTRUCTS AND USE THEREOF
#4480SELECTIVE IL-6-TRANS-SIGNALLING INHIBITOR COMPOSITIONS
#4481HSP Fusion Protein with Anti-Chemorepellant Agent for Treatment of Cancer
#4482Compositions, formulations and methods for treating ocular diseases
#4483RADIOPAQUE PARTICLE COMPOSITIONS AND USES THEREOF
#4484RNA constructs and uses thereof
#4485A METHOD OF ELICITING AN IMMUNE RESPONSE BY ADMINISTERING A POPULATION OF POLYMERSOMES HAVING AN ASSOCIATED ANTIGEN TOGETHER WITH A POPULATION OF POLYMERSOMES HAVING AN ASSOCIATED ADJUVANT AS WELL AS COMPOSITIONS COMPRISING THE TWO POPULATIONS OF POLYMERSOMES
#4486TAU PEPTIDE ANTIGENS AND ANTIBODIES BINDING THERETO FOR THE TREATMENT OF TAUOPATHIES
#4487SYSTEMS, COMPOSITIONS AND METHODS FOR TREATING DIABETES
#4488GIP/GLP1 agonist compositions
#4489METHODS FOR ADMINISTERING ANGIOTENSIN II BY MONITORING RENIN LEVELS
#4490CDC-DERIVED EXOSOMES FOR TREATMENT OF VENTRICULAR TACHYARRYTHMIAS
#4491THERAPEUTIC DRUGS FOR FIBROSIS, INFLAMMATION, AND/OR AGING DISEASES
#4492IMPROVED FORMULATIONS FOR IMMUNE CELLS
#4493Hydroxypropyl beta-cyclodextrin compositions and methods
#4494Therapeutic agent for nervous system disease
#4495Uses of Pulsatilla Chinensis extract in preparing drug for treating viral and/or bacterial diseases
#4496ACEFAPC FOR THE TREATMENT OF ACETYLCHOLINE-DEPENDENT DISEASES
#4497EXTENDED-RELEASE DRUG DELIVERY COMPOSITIONS
#4498Aqueous Suspensions of TMC278
#4499SUSTAINED RELEASE DRUG DELIVERY SYSTEMS AND RELATED METHODS
#4500INTRAVENOUS VITAMIN C THERAPY PROTOCOL FOR THE TREATMENT OF CANCER